Quick Answer
Inhibitor Therapeutics, Inc. reported Shares Outstanding of 172.57 million shares for fiscal year 2025.
Inhibitor Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 172.57M | +0.1% |
| 2024 | 172.32M | +0.2% |
| 2023 | 172.02M | +0.1% |
| 2022 | 171.79M | -54.4% |
| 2021 | 376.86M | +0.9% |
| 2020 | 373.64M | +0.9% |
| 2019 | 370.45M | +0.1% |
| 2018 | 370.08M | +0.1% |
| 2017 | 369.60M | +4.6% |
| 2016 | 353.45M | +44.1% |
| 2015 | 245.35M | +16.1% |
| 2014 | 211.42M | +1019.3% |
| 2013 | 18.89M | +21.4% |
| 2012 | 15.56M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 172.57M | +0.1% | +0.0% |
| June 30, 2025 | 172.57M | +0.1% | +0.1% |
| March 31, 2025 | 172.32M | +0.0% | +0.0% |
| December 31, 2024 | 172.32M | +0.2% | +0.0% |
| September 30, 2024 | 172.32M | +0.2% | +0.0% |
| June 30, 2024 | 172.32M | +0.2% | +0.0% |
| March 31, 2024 | 172.32M | +0.3% | +0.2% |
| December 31, 2023 | 172.02M | +0.1% | +0.0% |
- Inhibitor Therapeutics, Inc. showed an increase of +0.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, Inhibitor Therapeutics, Inc.’s shares outstanding has grown by 1009.0% (from 15.56 million shares to 172.57 million shares).
- The most recent figure is from Inhibitor Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: